We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current C1AH34 market cap is 155.39B. The company's latest EPS is USD 3.5028 and P/E is 34.90.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 54.8B | 57.46B | 54.91B | 59.71B | 52.32B |
Operating Income | 523M | 483M | 503M | -255M | 567M |
Net Income | 5M | 353M | 258M | 236M | 416M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 152.92B | 162.47B | 181.36B | 205.31B | 226.83B |
Operating Income | -3.51B | 549M | 1.46B | 1.98B | 1.2B |
Net Income | -3.7B | 611M | -933M | 261M | 852M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 43.71B | 46.57B | 45.88B | 45.12B | 43.06B |
Total Liabilities | 47.2B | 50.02B | 49.14B | 48.33B | 46.34B |
Total Equity | -3.49B | -3.45B | -3.26B | -3.21B | -3.28B |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 40.77B | 44.45B | 43.88B | 43.42B | 45.12B |
Total Liabilities | 38.97B | 42.66B | 44.58B | 46.27B | 48.33B |
Total Equity | 1.79B | 1.79B | -706M | -2.85B | -3.21B |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 545M | 1.73B | 1.69B | 2.41B | -1.65B |
Investing | -63M | -168M | -2.02B | -1.85B | -88M |
Financing | -666M | -1.02B | 12M | -847M | -540M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 1.96B | 2.43B | 3.12B | 2.84B | 2.41B |
Investing | 493M | -378M | 567M | -454M | -1.85B |
Financing | -2.2B | -1.32B | -2.46B | -3.05B | -847M |
Market Cap | 155.39B |
Price to Earnings Ratio | 34.90 |
Price to Sales Ratio | 0.13 |
Price to Cash Ratio | 5.79 |
Price to Book Ratio | -9.26 |
Dividend Yield | 1.28% |
Shares Outstanding | 243.23M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | 27.77% |
52 Week High | 641.28 |
52 Week Low | 492.50 |
Spread (Intraday) | 14.06 (1.91%) |
Company Name | Cardinal Health, Inc. |
Address |
4400 easton commons way columbus, georgia 43219 |
Website | https://www.cardinalhealth.com |
Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions